Cerbios collaborates with IRB on developing targeted leukemia antibodies

CERBIOS-PHARMA SA News Releases

Find the latest News from CERBIOS-PHARMA SA

Home / News Releases

Cerbios collaborates with IRB on developing targeted leukemia antibodies

Monday 4th February 2019

By CERBIOS-PHARMA SA Learn More >

US Ambassador visit signals closer American links for Cerbios-Pharma

Thursday 6th December 2018

By CERBIOS-PHARMA SA Learn More >

Cerbios-Pharma and PROVEO return to World ADC conference with enhanced one-stop offer

Thursday 8th November 2018

By CERBIOS-PHARMA SA Learn More >

Cerbios-Pharma showcasing chemical, ADC and biotechnology services at CPhI Worldwide 2018

Tuesday 18th September 2018

By CERBIOS-PHARMA SA Learn More >

Cerbios-Pharma brings new generic APIs and ADC technology to BIO Boston

Friday 1st June 2018

By CERBIOS-PHARMA SA Learn More >

Cerbios welcomes a comprehensive review on the efficacy and safety of its E. faecium SF68® probiotic

Monday 21st May 2018

By CERBIOS-PHARMA SA Learn More >

Senior Cerbios scientist says new generation ADCs demand manufacturing revolution

Tuesday 1st May 2018

By CERBIOS-PHARMA SA Learn More >

Cerbios-Pharma brings enhanced HPAI and ADC offers to InformEx 2018

Wednesday 11th April 2018

By CERBIOS-PHARMA SA Learn More >

Cerbios-Pharma joins PROVEO for the 8th ADC World Berlin 2018

Tuesday 27th March 2018

By CERBIOS-PHARMA SA Learn More >

Cerbios-Pharma brings its ADCs technology to DCAT 2018

Wednesday 28th February 2018

By CERBIOS-PHARMA SA Learn More >

Cerbios Pharma SA showcasing new nanoparticle technology at CPhI Worldwide

Thursday 5th October 2017

By CERBIOS-PHARMA SA Learn More >

Cerbios-Pharma boosts PROVEO™ team at WORLD ADC San Diego

Monday 4th September 2017

By CERBIOS-PHARMA SA Learn More >